Amlosafe-MT 25mg 10 Tablets

babies: not applicable. lactating mother: safe is prescribed by your doctor during breastfeeding. human studies have shown that no side effects to the baby. pregnancy: amlodipine, metoprolol succinate, metoprolol tartrate tablet is not safe to use during pregnancy.
human and animal data suggest that this drug may cause harmful effects on the developing. consult your doctor. alcohol: it is not safe to drink alcohol while taking amlodipine, metoprolol succinate, metoprolol tartrate. driving: amlodipine, metoprolol succinate, metoprolol tartrate tablet may cause dizziness, headache, nausea, dizziness, or tiredness.
do not drive these symptoms occurs because it may affect your ability to drive. kidney: safe if prescribed by your doctor in patients with kidney disease. dose adjustment is not required.
liver: use this medication with caution in patients with liver disease. consult your doctor.
consult your doctor. .

Depression Itching Nausea Rash Shortness of breath Slow heart rate Tiredness Abdominal pain Decreased blood pressure Diarrhea Fatigue Sleepiness.

amlodipine besylate in AMLOSAFE MT is a calcium channel blocker, and metoprolol is a beta-blocker. It works by relaxing the blood vessels and decreasing heart rate.
thus, it improves your blood flow..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• AMLOSAFE MT may cause dizziness, so get up slowly from the sitting and lying position. •Do not stop the medication unless told by your doctor. • inform your doctor if you are pregnant or breastfeeding..

• amlodipine besylate + atazanavir: concurrent use may result in increased amlodipine concentrations and increased risk of cardiotoxicity • amlodipine besylate + clarithromycin: concurrent use may result in increased amlodipine exposure • amlodipine besylate + clopidogrel: concurrent use may result in decreased antiplatelet effect and increased risk of thrombotic events • amlodipine besylate + cyclosporine: concurrent use may result in an increased risk of cyclosporine toxicity • amlodipine besylate + digoxin: concurrent use may result in an increased risk of complete heart block • metoprolol succinate + albuterol: concurrent use may result in decreased efficacy of albuterol • metoprolol succinate + clonidine: concurrent use may result in an increased risk of sinus bradycardia; exaggerated clonidine with drawl response • metoprolol succinate +diltiazem: concurrent use may result in an increased risk of hypotension, bradycardia, av conduction disturbances • metoprolol tartrate + albuterol: concurrent use may result in decreased efficacy of albuterol • metoprolol tartrate + ceritinib: concurrent use may result in an increased risk of bradycardia • metoprolol tartrate + rifampin: concurrent use may result in reduced metoprolol efficacy.